{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:51:09Z","timestamp":1765828269595,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Institute of Health","award":["5R44D032178-03"],"award-info":[{"award-number":["5R44D032178-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>According to the Center for Disease Control, there were more than 107,000 US drug overdose deaths in 2021, over 80,000 of which due to opioids. One of the more vulnerable populations is US military veterans. Nearly 250,000 military veterans suffer from substance-related disorders (SRD). For those seeking treatment, buprenorphine is prescribed to help treat opioid use disorder (OUD). Urinalysis is currently used to monitor buprenorphine adherence as well as to detect illicit drug use during treatment. Sometimes sample tampering occurs if patients seek to generate a false positive buprenorphine urine test or mask illicit drugs, both of which can compromise treatment. To address this problem, we have been developing a point-of-care (POC) analyzer that can rapidly measure both medications used for treatment and illicit drugs in patient saliva, ideally in the physi-cian\u2019s office. The two-step analyzer employs (1) supported liquid extraction (SLE) to isolate the drugs from the saliva and (2) surface-enhanced Raman spectroscopy (SERS) to detect the drugs. A prototype SLE-SERS-POC analyzer was used to quantify buprenorphine at ng\/mL concentrations and identify illicit drugs in less than 1 mL of saliva collected from 20 SRD veterans in less than 20 min. It correctly detected buprenorphine in 19 of 20 samples (18 true positives, 1 true negative and 1 false negative). It also identified 10 other drugs in patient samples: acetaminophen, amphetamine, cannabidiol, cocaethylene, codeine, ibuprofen, methamphetamine, methadone, nicotine, and norbuprenorphine. The prototype analyzer shows evidence of accuracy in measuring treatment medications and relapse to drug use. Further study and development of the system is warranted.<\/jats:p>","DOI":"10.3390\/molecules28052010","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T02:08:34Z","timestamp":1677031714000},"page":"2010","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of Drugs in Saliva of US Military Veterans Treated for Substance Use Disorders Using Supported Liquid Extraction and Surface-Enhanced Raman Spectral Analysis"],"prefix":"10.3390","volume":"28","author":[{"given":"Stuart","family":"Farquharson","sequence":"first","affiliation":[{"name":"Real-Time Analyzers, Inc., Middletown, CT 06457, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan","family":"Shende","sequence":"additional","affiliation":[{"name":"Real-Time Analyzers, Inc., Middletown, CT 06457, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenelle","family":"Newcomb","sequence":"additional","affiliation":[{"name":"VA Connecticut Healthcare System, West Haven, CT 06516, USA"},{"name":"Department of Psychiatry, School of Medicine, Yale University, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismene L.","family":"Petrakis","sequence":"additional","affiliation":[{"name":"VA Connecticut Healthcare System, West Haven, CT 06516, USA"},{"name":"Department of Psychiatry, School of Medicine, Yale University, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert J.","family":"Arias","sequence":"additional","affiliation":[{"name":"VA Connecticut Healthcare System, West Haven, CT 06516, USA"},{"name":"Department of Psychiatry, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"ref_1","unstructured":"(2022, November 11). U.S. Overdose Deaths In 2021 Increased Half as Much as in 2020\u2013But Are Still Up 15%, Available online: www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2022\/202205.htm#print."},{"key":"ref_2","unstructured":"Ahmad, F.B., Cisewski, J.A., Rossen, L.M., and Sutton, P. (2022, November 11). Provisional Drug Overdose Death Counts. National Center for Health Statistics, Available online: www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm."},{"key":"ref_3","unstructured":"Daigh, J., and Department of Veterans Affairs Office of Inspector General (2014). Healthcare Inspection\u2013VA Patterns of Dispensing Take-Home Opioids and Monitoring Patient on Opioid Therapy, Office of Healthcare Inspections. Report No. 14\u201300895\u2013163."},{"key":"ref_4","first-page":"155","article-title":"Treatment of co-occurring alcohol and other drug use disorders","volume":"31","author":"Arias","year":"2008","journal-title":"Alcohol Res. Health"},{"key":"ref_5","unstructured":"Dahl, N.H., and Department of Veterans Affairs Office of Inspector General (2017). Independent Review of VA\u2019s FY 2016 Detailed Accounting Submission of the Office of National Drug Control Policy, Office of Healthcare Inspections. Report No. 17\u201300976\u2013176."},{"key":"ref_6","unstructured":"Office of Public and Intergovernmental Affairs (2022, November 11). VA Reduces Prescription Opioid Use by 64% during Past Eight Years, Available online: www.va.gov\/opa\/pressrel\/pressrelease.cfm?id=5492."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/SAR.S116720","article-title":"Substance use disorders in military veterans: Prevalence and treatment challenges","volume":"8","author":"Teeters","year":"2017","journal-title":"Subst. Abuse Rehab."},{"key":"ref_8","unstructured":"Childress, S. (2022, November 11). Veterans Face Greater Risks Amid Opioid Crisis. Public Broadcasting System-Front Line. Available online: www.pbs.org\/wgbh\/frontline\/article\/veterans-face-greater-risks-amid-opioid-crisis\/."},{"key":"ref_9","first-page":"4","article-title":"Veterans\u2019 health and opioid safety-contexts, risks, and outreach implications","volume":"32","author":"Bennett","year":"2015","journal-title":"Fed. Pract."},{"key":"ref_10","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"6","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-197917020-00001","article-title":"Buprenorphine: A review of its pharmacological properties and therapeutic effects","volume":"17","author":"Heel","year":"1979","journal-title":"Drugs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drugalcdep.2012.12.009","article-title":"A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence","volume":"131","author":"Lintzeris","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"ref_13","unstructured":"(2013, July 16). Suboxone\u00ae Sublingual Film. Richmond: Reckitt Benckiser Pharmaceuticals Inc. Available online: www.suboxone.com\/patients\/about_suboxone\/about_suboxone_film.aspx#10."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: The current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"J. Addict. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10550880903014767","article-title":"Diversion of buprenorphine\/naloxone coformulated tablets in a region with high prescribing prevalence","volume":"28","author":"Monte","year":"2009","journal-title":"J. Addict. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.9740\/mhc.n186952","article-title":"Buprenorphine for opioid dependence: Are there really differences between the formulations?","volume":"4","author":"Graham","year":"2014","journal-title":"Mental Health Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jat\/32.7.516","article-title":"Urinary buprenorphine concentrations in patients treated with suboxone as determined by liquid chromatography-mass spectrometry and CEDIA immunoassay","volume":"32","author":"Hull","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/08897077.2017.1356796","article-title":"Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment","volume":"38","author":"Suzuki","year":"2017","journal-title":"Subst. Abus."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.forsciint.2004.02.035","article-title":"Ludes, P. Kintz. Evaluation of the One-Step TM ELIZA kit for the detection of buprenorphine in urine, blood, and hair","volume":"143","author":"Cirimele","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jat\/30.2.115","article-title":"Validation of the Immunanlysis\u00ae microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine","volume":"30","author":"Miller","year":"2006","journal-title":"J. Anal. Toxicol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S88935","article-title":"Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: Influence of dose and metabolites of opioids","volume":"6","author":"Berg","year":"2015","journal-title":"Subst. Abuse Rehabil."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jat\/bkw001","article-title":"Use of an acetyl derivative to improve GC-MS determination of norbuprenorphine in the presence of high concentrations of buprenorphine in urine","volume":"40","author":"Gervais","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/jat\/bky053","article-title":"Quantitative analysis of novel synthetic opioids, morphine and buprenorphine in oral fluid by LC-MS-MS","volume":"42","author":"Truver","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jpba.2019.01.014","article-title":"Rapid, hydrolysis-free, dilute-and-shoot method for the determination of buprenorphine, norbuprenorphine and their glucuronides in urine samples using UHPLC-MS\/MS","volume":"166","author":"Agostini","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/dta.3104","article-title":"Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry","volume":"13","author":"Mariottini","year":"2021","journal-title":"Drug Test Anal."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jrs.1277","article-title":"Analysis of 5-fluorouracil in saliva using surface-enhanced Raman spectroscopy","volume":"36","author":"Farquharson","year":"2005","journal-title":"J. Raman Spectrosc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1366\/11-06310","article-title":"Detection of Drugs of Abuse in Saliva by SERS","volume":"65","author":"Inscore","year":"2011","journal-title":"Appl. Spectrosc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3390\/molecules24142578","article-title":"Quantitative Measurements of Codeine and Fentanyl on a Surface-Enhanced Raman-Active Pad","volume":"24","author":"Shende","year":"2019","journal-title":"Molecules"},{"key":"ref_29","first-page":"3","article-title":"Detection of Tacrolimus in Saliva using a Lateral Flow Assay and Surface-Enhanced Resonance Raman Scattering","volume":"13","author":"Shende","year":"2022","journal-title":"J. Anal. Bioanal. Tech."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1063\/1.448657","article-title":"Surface-enhancement factors for Raman scattering at silver electrodes. Role of adsorbate-surface interactions and electrode structure","volume":"82","author":"Weaver","year":"1985","journal-title":"J. Chem. Phys."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1126\/science.275.5303.1102","article-title":"Probing single molecules and single nanoparticles by surface-enhanced Raman scattering","volume":"275","author":"Nie","year":"1997","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3389\/fchem.2019.00706","article-title":"A surface-enhanced Raman spectral library of important drugs associated with point-of-care and field applications","volume":"7","author":"Farquharson","year":"2019","journal-title":"Front. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.1993.tb18346.x","article-title":"Saliva testing for drugs of abuse","volume":"694","author":"Cone","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4172\/2155-9872.1000368","article-title":"Identification of Buprenorphine in Patient Saliva","volume":"8","author":"Farquharson","year":"2017","journal-title":"J. Anal. Bioanal. Tech."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gemperline, P. (2006). Practical Guide to Chemometrics, CRC Press. [2nd ed.].","DOI":"10.1201\/9781420018301"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/pharmaceutics3030425","article-title":"Rapid detection and identification of overdose drugs in saliva by surface-enhanced Raman scattering using fused gold colloids","volume":"3","author":"Farquharson","year":"2011","journal-title":"Pharmaceutics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine\/naloxone: A review of its use in the treatment of opioid dependence","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.3390\/molecules13102608","article-title":"Surface-enhanced Raman Spectral Measurements of 5-Fluorouracil in Saliva","volume":"13","author":"Farquharson","year":"2008","journal-title":"Molecules"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/009127009703700106","article-title":"Bioavailability of sublingual buprenorphine","volume":"37","author":"Mendelson","year":"1997","journal-title":"J. Clin. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1021\/j100214a025","article-title":"Adsorption and surface-enhanced Raman of dyes on silver and gold sols","volume":"86","author":"Lee","year":"1982","journal-title":"J. Phys. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/5\/2010\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:37:59Z","timestamp":1760121479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/5\/2010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["molecules28052010"],"URL":"https:\/\/doi.org\/10.3390\/molecules28052010","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}